Sign in
4

Changes in Ownership

CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001209191-17-062466

Director bought 3,300 shares at $7.55 ($24,915)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Krogulski Kenneth Director 2017-11-20 Purchase +3,300 $7.55 $24,915 154,300 D
Open-market purchases · 3,300 sh · avg $7.55 · $24,915
Loading xslF345X03/doc4.xml…